UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors

Endocrine-related cancer, 2016-09, Vol.23 (9), p.759-767

2016

Volltextzugriff (PDF)

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood

Annals of oncology, 2020-02, Vol.31 (2), p.202-212

2020

Volltextzugriff (PDF)

Analysis of the immune landscape of small bowel neuroendocrine tumors

Endocrine-related cancer, 2019-01, Vol.26 (1), p.119-130

2019

Volltextzugriff (PDF)

A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors

Annals of oncology, 2012-09, Vol.23 (9), p.2335-2341

2012

Volltextzugriff (PDF)

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms

ESMO open, 2022-02, Vol.7 (1), p.100364-100364, Article 100364

2022

Volltextzugriff (PDF)

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of oncology, 2023-10, Vol.34, p.S1292-S1292

2023

Volltextzugriff (PDF)

O-20 Phase I/IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Annals of oncology, 2020-07, Vol.31, p.239

2020

Volltextzugriff (PDF)

Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors

Endocrine-related cancer, 2015-02, Vol.22 (1), p.1-9

2015

Volltextzugriff (PDF)

A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients

Annals of oncology, 2012-05, Vol.23 (5), p.1335-1340

2012

Volltextzugriff (PDF)

A phase II study of axitinib in advanced neuroendocrine tumors

Endocrine-related cancer, 2016-05, Vol.23 (5), p.411-418

2016

Volltextzugriff (PDF)

Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors

ESMO open, 2024-04, Vol.9 (4), p.102386-102386, Article 102386

2024

Volltextzugriff (PDF)

Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)

Annals of oncology, 2018-10, Vol.29, p.viii467-viii468

2018

Volltextzugriff (PDF)

Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study

Annals of oncology, 2018-10, Vol.29, p.viii471-viii471

2018

Volltextzugriff (PDF)

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

Endocrine-related cancer, 2013-06, Vol.20 (3), p.383-390

2013

Volltextzugriff (PDF)

The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET)

Annals of oncology, 2018-10, Vol.29, p.viii473-viii473

2018

Volltextzugriff (PDF)

1194P Do metastatic appendiceal NETs ever develop metachronously after appendectomy or right hemicolectomy?

Annals of oncology, 2023-10, Vol.34, p.S705-S705

2023

Volltextzugriff (PDF)

Pancreatic NETs: where do we stand now?

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.361-366

2014

Volltextzugriff (PDF)

SP-0570: Neuroendocrine tumours - personalised diagnosis and treatment using radiolabelled peptides

Radiotherapy and oncology, 2016-04, Vol.119, p.S274-S275

2016

Volltextzugriff (PDF)

6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S710-S710

2015

Volltextzugriff (PDF)

5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study

European journal of cancer (1990), 2015-09, Vol.51, p.S709-S710

2015

Volltextzugriff (PDF)

Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors

The New England journal of medicine, 2017-01, Vol.376 (2), p.125

2017

Volltextzugriff (PDF)

Ablative MRI-Guided Radiation for GI Neuroendocrine Tumors: Assessment of Local Control and Toxicity

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e479-e480

2024

Volltextzugriff (PDF)

Analyse de la PFS de l’étude NETTER-1 chez des patients présentant une TNE intestinale dans des sous-groupes de mauvais pronostic avec atteinte hépatique

Médecine nucléaire : imagerie fonctionelle et métabolique, 2020-03, Vol.44 (2), p.96-97

2020

Volltextzugriff (PDF)

Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma

Current oncology (Toronto), 2016-02, Vol.23 (1), p.e70-74

2016

Volltextzugriff (PDF)

PD-2 Final result of phase IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Annals of oncology, 2021-07, Vol.32, p.S199

2021

Volltextzugriff (PDF)

1 – 25 von 497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(448)
Mit Volltextzugriff
(385)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(198)
Humans
(148)
Animals
(143)
Biological And Medical Sciences
(90)
Male
(65)
Fundamental And Applied Biological Sciences. Psychology
(62)
Female
(60)
Middle Aged
(47)
Biochemistry & Molecular Biology
(45)
Amino Acid Sequence
(44)
Adult
(43)
Mice
(42)
Molecular Sequence Data
(39)
Oncology
(37)
Aged
(34)
Rats
(31)
Medical Sciences
(30)
Molecular And Cellular Biology
(28)
Pharmacology & Pharmacy
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood

Analysis of the immune landscape of small bowel neuroendocrine tumors

A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

O-20 Phase I/IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors

A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients

A phase II study of axitinib in advanced neuroendocrine tumors

Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors

Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)

Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

The commonwealth neuroendocrine tumour collaboration (CommNETs) and North American neuroendocrine tumor society (NANETS) endorsement and update of European neuroendocrine tumor society (ENETS) best practice consensus for lung neuroendocrine tumors (LNET)

1194P Do metastatic appendiceal NETs ever develop metachronously after appendectomy or right hemicolectomy?

Pancreatic NETs: where do we stand now?

SP-0570: Neuroendocrine tumours - personalised diagnosis and treatment using radiolabelled peptides

6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study

Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors

Ablative MRI-Guided Radiation for GI Neuroendocrine Tumors: Assessment of Local Control and Toxicity

Analyse de la PFS de l’étude NETTER-1 chez des patients présentant une TNE intestinale dans des sous-groupes de mauvais pronostic avec atteinte hépatique

Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma

PD-2 Final result of phase IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer

Suchergebnisse filtern